ℹ️ Compiled from public regulatory records · Last regulator revision: May 29, 2026🚩 Report this page
Tyrosine
Active ingredient
Sold as AMINOVEN 25
GB MHRA
- Drug class
- -
- Availability
- See label
- Markets covered
- 1
- Products on record
- 3
Overview
Tyrosine is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 3 | May 29, 2026 |
GBUnited Kingdom· MHRA
3 products
Uses
For supply of amino acids as part of a parenteral nutrition regimen. Aminoven 15% is mainly indicated if during parenteral nutrition therapy the fluid volume has to be restricted. Amino acid solutions should be administered generally in combination with adequate amount of energy supplements.
How to take
Sources & citations
- [1]MHRA (UK) · PL088280129 · revised June 20, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.